Invasive lobular breast cancer makes up about 10 to 15 percent of all breast cancers diagnosed in the U.S. Patients with this breast cancer subtype are organizing and advocating for more scientific research into how this cancer differs from the more common invasive ductal breast cancer and for clinical trials that focus on this subtype.
Below you will find links to the Lobular Breast Cancer Alliance; a feature story by Diane Mapes, a journalist and LBCA patient research advocate; published research on metastatic LBC; a Facebook group specifically for individuals with metastatic LBC; and two conference presentations on metastatic LBC.
- Lobular Breast Cancer Alliance
- Oncologist: Comprehensive review of molecular mechanisms and clinical features of invasive lobular cancer
- National Library of Medicine: Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast
- Diane Mapes: Lobular Breast Cancer Comes Into the Spotlight
- Metastatic LBC Facebook Group: Support for People with Metastatic Lobular Breast Cancer
- 2017 NW Metastatic Breast Cancer Conference: Lobular Breast Cancer 101: Fundmentals
- 2017 NW Metastatic Breast Cancer Conference: Lobular Breast Cancer 102: Metastasis & Clinical
- Use Metastatic Trial Search to find trials for lobular breast cancer
Last Modified on March 15, 2021